Kalohexis Shares 710GO Data Supporting Durable Weight Loss
NORTHBROOK, Ill., July 15, 2026 Kalohexis, Inc., a clinical-stage biotechnology company developing innovative therapies for metabolic diseases, has unveiled...
IL-5
Advertisement
Bambusa Reports Promising BBT002 Data for COPD Therapy
BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary multiple ascending dose (MAD) Phase 1 clinical data for...
Bambusa Therapeutics Reports Positive Phase 1 BBT002 Data at EAACI 2026
BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...
GSK Wins China Approval for Exdensur in Severe Asthma
LONDON, UK — March 30, 2026 In a major advancement in respiratory medicine and biologic drug innovation, GSK plc...
Advertisement
